These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10764958)

  • 21. Novel peptide-based pepsin inhibitors containing an epoxide group.
    Ito H; Hirono T; Morita Y; Nemoto Y; Kim YT; Takahashi K
    J Enzyme Inhib Med Chem; 2008 Jun; 23(3):352-6. PubMed ID: 18569339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific inhibition of human group I pepsins by two pepsin inhibitiors.
    Murakami K; Misaki F; Sasaki Z; Tanaka T; Kawai K
    Gastroenterol Jpn; 1977; 12(3):199-201. PubMed ID: 336448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a pepsin-inhibitory pentapeptide upon the peptic activity and acidity of gastric secretion.
    Svendsen LB; Guldager N; Christensen L; Christiansen PM
    Scand J Gastroenterol; 1976; 11(5):459-64. PubMed ID: 785587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological activity of new conformationally restricted analogues of pepstatin.
    Szewczuk Z; Rebholz KL; Rich DH
    Int J Pept Protein Res; 1992; 40(3-4):233-42. PubMed ID: 1478780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: Effect of a pepsin-inhibitory pentapeptide upon the gastric secretion of pepsin and hydrochloric acid.
    Christiansen PM; Svendsen LB; Guldager N; Christensen L
    Gut; 1975 Oct; 16(10):823-4. PubMed ID: 1107170
    [No Abstract]   [Full Text] [Related]  

  • 26. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
    Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
    Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of novel semi-synthetic tight binding inhibitors of pepsin.
    Huddy SP; Patel G; Heywood GC; Austen BM; Hermon-Taylor J
    Biochem Soc Trans; 1989 Dec; 17(6):1124-5. PubMed ID: 2516823
    [No Abstract]   [Full Text] [Related]  

  • 28. N-acylated derivatives of a peptide obtained by enzymatic degradation of pepstatins.
    Matsushita Y; Tone H; Hori S; Yagi Y; Takamatsu A
    J Antibiot (Tokyo); 1975 Dec; 28(12):1016-8. PubMed ID: 1107282
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of cathepsin D by tripeptides containing statine analogs.
    Bessodes M; Antonakis K; Herscovici J; Garcia M; Rochefort H; Capony F; Lelièvre Y; Scherman D
    Biochem Pharmacol; 1999 Jul; 58(2):329-33. PubMed ID: 10423175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inactivation of Penicillium roqueforti acid protease by specific pepsin inhibitors.
    Gripon JC
    Biochimie; 1976; 58(6):747-9. PubMed ID: 782567
    [No Abstract]   [Full Text] [Related]  

  • 31. Design, synthesis and structure-activity study of shorter hexa peptide analogues as HIV-1 protease inhibitors.
    Narendra Babu SN; Rangappa KS
    Bioorg Med Chem; 2008 Jan; 16(2):874-80. PubMed ID: 17981043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New class of inhibitors specific for human renin.
    Papaioannou S; Hansen D; Babler M; Yang PC; Bittner S; Miller A; Clare M
    Clin Exp Hypertens A; 1985; 7(9):1243-57. PubMed ID: 3000656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative pepstatin inhibition studies on individual human pepsins and pepsinogens 1,3 and 5(gastricsin) and pig pepsin A.
    Roberts NB; Taylor WH
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):209-17. PubMed ID: 14506911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of protein turnover in human lung cells by pepstatin and tripeptide analogs of pepstatin.
    Owens RA; Liu WS; Glover GI; Gunn JM
    Biochem Pharmacol; 1979 Apr; 28(7):1263-6. PubMed ID: 444285
    [No Abstract]   [Full Text] [Related]  

  • 35. Hybrid 2D/3D-quantitative structure-activity relationship and modeling studies perspectives of pepstatin A analogs as cathepsin D inhibitors.
    Arodola OA; Soliman ME
    Future Med Chem; 2018 Jan; 10(1):5-26. PubMed ID: 29235371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate specificity and screening of the integral membrane protease Pla.
    Agarkov A; Chauhan S; Lory PJ; Gilbertson SR; Motin VL
    Bioorg Med Chem Lett; 2008 Jan; 18(1):427-31. PubMed ID: 17981463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonspecific electrostatic binding of substrates and inhibitors to porcine pepsin.
    Kuzmic P; Sun CQ; Zhao ZC; Rich DH
    Adv Exp Med Biol; 1991; 306():75-86. PubMed ID: 1812761
    [No Abstract]   [Full Text] [Related]  

  • 38. Biological activity of pepstatins, pepstanone A and partial peptides on pepsin, cathepsin D and renin.
    Aoyagi T; Morishima H; Nishizawa R; Kunimoto S; Takeuchi T
    J Antibiot (Tokyo); 1972 Dec; 25(12):689-94. PubMed ID: 4568691
    [No Abstract]   [Full Text] [Related]  

  • 39. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
    Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M
    Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical modification of a pepsin inhibitor from the activation peptides of pepsinogen.
    Kumar PM; Ward PH; Kassell B
    Adv Exp Med Biol; 1977; 95():211-22. PubMed ID: 339691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.